Worldwide Joint Pain Injection Industry to 2028 - by Drug, Joint Type, Distribution Channel and Geography

DUBLIN, May 19, 2021 /PRNewswire/ -- The "Joint Pain Injection Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Drug, Joint Type, and Distribution Channel" report has been added to ResearchAndMarkets.com's offering.

The joint pain injection market is expected to reach US$ 6,996.88 million in 2028 from US$ 3,667.45 million in 2020; it is estimated to grow at a CAGR of 8.5% from 2021 to 2028. The growth of the market is mainly attributed to the high prevalence of musculoskeletal disorders and increasing number of sports injuries. However, the high costs of joint repair therapies hinder the market growth.

Hyaluronic acid injections are usually administered for treating sports injuries, as they aid in pain relief, reduce inflammation, and improve joint function. Corticosteroids are also used to treat sports-related injuries. Sports injuries are caused due to direct impact or due to the application of force that is larger than the body part can withstand. The most common sport injuries are sprains, strains, joint injuries, and bruises. As per the National Safety Council (NSC), in 2019, exercise accounted for ~468,000 injuries in the US, the most of any category of sports and recreation. People involved in football, bicycling, basketball, playground, and soccer activities contributed to the highest number of emergency department (ED) visits in that year. It also states sport injuries affect over thousands of youth population engaged in various sports. Further, according to a research from the Australian Institute of Health and Welfare, ~60,000 people were hospitalized due to sports injuries in 2016-2017. Additionally, according to the European Injury Data Base (IDB) sports, annually ~4.5 million people aged 15 years and above approach EU hospitals for the treatment of sport injuries. Thus, the growing number of sport injuries is boosting the demand for joint pain injections.

Based on joint type, the joint pain injection market is segmented into knee, shoulder and elbow, hip, foot and ankle, and others. In 2020, the knee joint type segment accounted for the largest share of the market. Growth of this segment is attributed to the increasing prevalence of knee injuries. For instance, according to a study published in the Journal of Osteoarthritis and Cartilage in 2020, ~303 million people across the world suffer from osteoarthritis, and ~60.0% of this population suffers from knee pain. Furthermore, growing number of product launches for knee pain treatment are also driving the growth of the market for the knee segment.

The World Health Organization (WHO), National Health Service, Centers for Disease Control and Prevention (CDC), Organization for Economic Co-operation and Development (OECD), American Academy of Orthopedic Surgeons, Australian Institute of Health, European Injury Data Base (IDB) and Welfare, and National Safety Council along with company websites are among the major primary and secondary sources referred to while preparing the report on the joint pain injection market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the joint pain injection market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the global joint pain injection market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Joint Pain Injection Market - By Drug
1.3.2 Global Joint Pain Injection Market - By Joint Type
1.3.3 Global Joint Pain Injection Market - By Distribution Channel
1.3.4 Global Joint Pain Injection Market - By Geography

2. Joint Pain Injection Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Joint Pain Injection - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions

5. Joint Pain Injection Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Prevalence of Musculoskeletal Disorders
5.1.2 Increasing Number of Sports Injuries
5.2 Market Restraints
5.2.1 High Costs of Joint Repair Therapies
5.3 Market Opportunities
5.3.1 Proliferation of Pharmaceutical Sector in Emerging Markets
5.4 Future Trends
5.4.1 Product Innovations
5.5 Impact Analysis

6. Joint Pain Injection Market - Global Analysis
6.1 Global Joint Pain Injection Market Revenue Forecast And Analysis
6.2 Global Joint Pain Injection Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Joint Pain Injection Market Analysis - By Drugs
7.1 Overview
7.2 Joint Pain Injection Market Revenue Share, by Drugs (2020 and 2028)
7.3 Hyaluronic Acid
7.3.1 Overview
7.3.2 Hyaluronic Acid: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Corticosteroid
7.4.1 Overview
7.4.2 Corticosteroid: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)

8. Joint Pain Injection Market Analysis - By Joint Type
8.1 Overview
8.2 Joint Pain Injection Market Revenue Share, by Joint Type (2020 and 2028)
8.3 Knee
8.3.1 Overview
8.3.2 Knee: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Hip
8.4.1 Overview
8.4.2 Hip: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Foot and Ankle
8.5.1 Overview
8.5.2 Foot and Ankle: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Shoulder and Elbow
8.6.1 Overview
8.6.2 Shoulder and Elbow: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)

9. Joint Pain Injection Market Analysis - By Distribution Channel
9.1 Overview
9.2 Joint Pain Injection Market Share, by Distribution Channel, 2020 and 2028, (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Retail Pharmacies
9.4.1 Overview
9.4.2 Retail Pharmacies: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Joint Pain Injection Market - Revenue and Forecast to 2028 (US$ Million)

10. Joint Pain Injection Market - Geographical Analysis
10.1 North America: Joint Pain Injection Market Revenue and Forecast to 2028
10.2 Europe: Joint Pain Injection Market Revenue and Forecast to 2028
10.3 Asia Pacific: Joint Pain Injection Market Revenue and Forecast to 2028
10.4 Middle East & Africa: Joint Pain Injection Market Revenue and Forecast to 2028
10.5 South and Central America: Joint Pain Injection Market Revenue and Forecast to 2028

11. Impact of COVID-19 Pandemic on Global Joint Pain Injection Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Joint Pain Injection Market - Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/9degoq

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets